Skip to main content
ManuSights

Reference notes

Coverage

56 journal planning records · 4 policy routes

Sources

Feb. 2026 publisher snapshot · official funder policies

Last reviewed

Policy guidance: September 2026 · data: February 2026

Prepared by the Manusights editorial team.

Publishing-route guide

Open Access Publishing in Biomedicine: APCs, Mandates, and Journal Options

Open-access obligations can change where you submit, which manuscript version you deposit, and whether an APC is actually needed. The answer depends on your award, not a single rule that applies to every funder.

Start with the policy route that applies to your award, then compare the publishing route. The 56-journal dataset is a February 2026 planning snapshot: APCs and institutional agreements change, so verify the current journal price and your library's eligibility before deciding.

Quick orientation

Use this page when the journal decision is constrained by funder policy, APC budget, or the practical route to compliance.

This guide is designed for manuscript planning, not just policy reading. It helps teams map the mandate first, then compare journal models, then check whether institutional agreements or waiver routes change the real cost.

56 journals4 policy routesAPC rangesWaiver notes

In this guide

The five sections that matter most for OA planning

Start with the mandate only if a funder is setting the rules. Most submission teams should move quickly from policy to journal model, then into the APC dataset and the practical cost-reduction routes.

Major OA Mandates in Biomedicine

NIH (USA)

Public access

Effective: July 1, 2025 (manuscripts accepted on or after this date)

For in-scope NIH-funded work, the Author Accepted Manuscript must be submitted to PubMed Central upon acceptance and made publicly available without embargo on the official publication date. This is a public-access route; do not assume it requires buying the journal's OA option or that it sets a blanket CC BY licence.

UKRI (UK)

Immediate route

Effective: Research articles submitted on or after April 1, 2022

In-scope research articles may use a compliant immediate-OA publisher route or a repository route for the Author Accepted Manuscript. The open version must carry CC BY or a permitted exception, and a publisher embargo is not permitted for the repository route.

Wellcome Trust

Europe PMC

Effective: Current policy updated January 2025

Original research supported by Wellcome must have a version available in Europe PMC on publication under CC BY, with a CC BY-ND exception available in defined cases. Since January 2025, Wellcome funds reasonable APCs only for qualifying fully OA journals or platforms; a compliant Author Accepted Manuscript or preprint route may also be available.

European Research Council (ERC)

Grant-specific

Effective: Requirements differ between Horizon 2020 and Horizon Europe grants

For Horizon Europe ERC projects, deposit the accepted manuscript or published version in an open repository and make it available immediately on publication with CC BY or an equivalent licence. Horizon 2020 projects use different deposit and embargo requirements. Read the grant agreement before treating an ERC route as interchangeable with another funder policy.

Practical implication: Do not treat a funder name as a publishing instruction. Confirm the award's scope, the permitted version, required licence, repository, and embargo rule before you submit. A fully OA journal, a hybrid option, or an accepted-manuscript deposit may be viable, but the compliant route is determined by the policy and your journal's terms.

OA Models: Gold, Hybrid, and Green

🟡 Gold OA

The journal is fully open access: all articles are freely available to anyone, immediately on publication. The author (or their funder) pays an APC.

Examples: PLOS ONE, Nature Communications, Genome Biology, eLife

🔵 Hybrid OA

The journal is subscription-based, but authors can pay an additional APC to make their specific article OA. Many subscription journals offer this route.

Examples: Nature, NEJM, Lancet, JAMA, and Cell all offer hybrid OA

🟢 Green OA

The accepted manuscript (not the final typeset PDF) is posted to a repository like PubMed Central, Europe PMC, or an institutional repository. This can avoid an APC, but compliance depends on the funder route and the journal's self-archiving policy.

All major journals permit some version of green OA: embargo periods and version rules vary. Check SHERPA/RoMEO for specific journal policies.

Gold and hybrid open-access options by journal

This February 2026 planning snapshot compares fully open-access journals, hybrid journals with optional OA, approximate APCs, and waiver availability. The default view includes both fully OA and hybrid titles so you can compare the tradeoff directly, then verify the current price and route.

Open access publishing options by journal

A February 2026 planning snapshot. Compare the route that matters first: fully open versus hybrid, approximate APC, and whether the publisher offers a waiver path. Verify live price, agreement eligibility, and policy route before relying on a record.

JournalOA modelAPCWaiver
PLOS ONEGold OA$1,931Yes
PLOS MedicineGold OA$3,500Yes
eLifeGold OA~$2,000Yes
Nature CommunicationsGold OA$9,750No
Science AdvancesGold OA$5,000No
Genome BiologyGold OA$2,890Yes
BMC MedicineGold OA$3,290Yes
Scientific ReportsGold OA$2,490No
Frontiers in ImmunologyGold OA$1,299No
BMJ OpenGold OA$2,500Yes
The LancetHybrid OA~$5,500No
NEJMHybrid OA~$6,000No
JAMAHybrid OA~$4,500No
Nature MedicineHybrid OA~$11,690No
NatureHybrid OA~$11,690No
ScienceHybrid OA~$4,500No
Cancer CellHybrid OA~$9,900No
The BMJHybrid OA~$4,200No
CellHybrid OA~$9,900No
Nature BiotechnologyHybrid OA~$11,690No
Journal of Clinical OncologyHybrid OA~$4,000No
CirculationHybrid OA~$4,500No
European Heart JournalHybrid OA~$4,000No
The Lancet OncologyHybrid OA~$5,500No
Cell MetabolismHybrid OA~$9,900No
Nature GeneticsHybrid OA~$11,690No
Nature ImmunologyHybrid OA~$11,690No
Nature NeuroscienceHybrid OA~$11,690No
ImmunityHybrid OA~$9,900No
GastroenterologyHybrid OA~$4,000No
GUTHybrid OA~$4,200No
JACCHybrid OA~$4,500No
Lancet Infectious DiseasesHybrid OA~$5,500No
JAMA OncologyHybrid OA~$4,500No
Lancet NeurologyHybrid OA~$5,500No
Cell Host & MicrobeHybrid OA~$9,900No
Cell Stem CellHybrid OA~$9,900No
Nature MethodsHybrid OA~$11,690No
NeuronHybrid OA~$9,900No
Circulation ResearchHybrid OA~$4,500No
Molecular CellHybrid OA~$9,900No
JAMA CardiologyHybrid OA~$4,500No
HepatologyHybrid OA~$4,000No
Journal of Clinical InvestigationHybrid OA~$3,500No
Nature Chemical BiologyHybrid OA~$11,690No
Science Translational MedicineHybrid OA~$4,500No
Nature Structural & Molecular BiologyHybrid OA~$11,690No
BrainHybrid OA~$3,500No
The EMBO JournalHybrid OA~$5,000No
Molecular PsychiatryHybrid OA~$11,690No
Current BiologyHybrid OA~$9,900No
Developmental CellHybrid OA~$9,900No
BloodHybrid OA~$4,500No
PNASHybrid OA~$2,250Yes
Cell ReportsHybrid OA~$9,900No
Nucleic Acids ResearchHybrid OA~$3,000No

Practical Advice on APCs

Check institutional agreements first

Many research universities have read-and-publish agreements with Springer Nature, Wiley, Elsevier, and other publishers that let corresponding authors publish OA at no direct cost. Before paying an APC out of pocket, ask your library whether a transformative agreement covers your target journal. Many researchers don't know these agreements exist.

Budget OA costs before you submit

If your grant requires open access, budget for APC costs in your grant application. Eligible publication costs depend on the award and policy. Ask your grants office or library before treating an APC as covered, and do it before acceptance creates time pressure.

Waivers are real and underused

PLOS and BMC both have formal waiver programs. Researchers at institutions without library subscriptions or in low-income countries often qualify. Even where formal waivers don't exist, editors at some journals have discretion: if you're unfunded, it doesn't hurt to ask.

Preprint posting is free

Posting to bioRxiv or medRxiv can make work visible while it is under review, and a preprint can be part of a compliant route for some funders. It does not automatically satisfy every funder or journal requirement. Check the policy and the target journal's terms before relying on it.

Data Sources & Disclaimers

  • APC figures: A February 2026 publisher-price snapshot, not a live quote. APCs, currency treatment, and agreement eligibility change regularly. Verify the journal's current author instructions and your institution's route before submission.
  • Policy information: Reviewed against the linked NIH, UKRI, Wellcome, and ERC guidance in September 2026. Policies and award terms evolve; the current funder page and grant agreement control.
  • Institutional agreements: Coverage varies by institution and changes as agreements are negotiated. Your library is the authoritative source.
  • Impact factors: Clarivate JCR 2024.
  • Journal routes: A journal appearing in this table is not a compliance certification. The route can depend on the manuscript version, funder, corresponding author, licence, repository, and agreement terms.

References

  1. Budapest Open Access Initiative. (2002). Budapest Open Access Initiative. Open Society Institute. [budapestopenaccessinitiative.org ↗]
  2. National Institutes of Health. (2025). NIH Public Access Policy overview. U.S. Department of Health and Human Services. [grants.nih.gov ↗]
  3. UK Research and Innovation. (2026). Making your research article open access. [ukri.org ↗]
  4. Wellcome. (2025). Complying with our open access policy. [wellcome.org ↗]
  5. SHERPA/RoMEO. (2026). Publisher copyright and self-archiving policies database. Jisc. [sherpa.ac.uk/romeo ↗]
  6. Creative Commons. (2013). Attribution 4.0 International (CC BY 4.0) License. [creativecommons.org ↗]
  7. European Research Council. (2026). Open science in ERC projects. [erc.europa.eu ↗]

Practical note

Three mistakes that make OA planning harder than it needs to be

Treating APC price as fixed before checking whether the library has a read-and-publish agreement.
Assuming every funder mandate requires the same license, embargo rules, or route to compliance.
Waiting until acceptance to learn whether the budget, waiver, or repository route actually works for the target journal.

Cite this resource

Citation formats

Free to use and cite, with attribution. See the reuse policy for what you may republish.

APA
Manusights. (2026). Open access publishing in biomedicine: APCs, mandates, and journal options (Policy guidance reviewed September 2026; journal data snapshot February 2026). https://manusights.com/resources/open-access-guide
MLA
Manusights. "Open Access Publishing in Biomedicine: APCs, Mandates, and Journal Options." Manusights, policy guidance reviewed Sept. 2026; journal data snapshot Feb. 2026, manusights.com/resources/open-access-guide.
Vancouver
Manusights. Open access publishing in biomedicine: APCs, mandates, and journal options [Internet]. Policy guidance reviewed Sep 2026; journal data snapshot Feb 2026. Available from: https://manusights.com/resources/open-access-guide

Related reference pages

Frequently Asked Questions

What is the difference between gold, green, and diamond open access?

Gold open access means the final published version is immediately freely available, typically funded by an article processing charge (APC) paid by the author or their institution. Green open access means the author self-archives an accepted manuscript version in a repository (institutional or subject-based like PubMed Central) after a publisher embargo period, with no APC required. Diamond open access is a subset of gold where neither authors nor readers pay - the journal is funded by institutions, grants, or societies. Most major subscription journals now offer a hybrid gold option for authors who need to comply with funder mandates.

Do I have to pay an APC to publish open access?

Not always. APC eligibility depends on your funder, award, journal, and institutional agreement. For example, Wellcome funds reasonable APCs only for qualifying fully OA venues, while many institutions have publisher agreements that may cover eligible corresponding authors. A compliant repository route can avoid an APC for some funder policies, but check the policy and journal terms before relying on it. Diamond OA journals charge no APC and some publishers offer waivers. Before paying out of pocket, ask your library about eligible agreements and check your funder's current guidance.

Which Creative Commons license should I choose for my open access paper?

Start with your funder and award conditions, because licences are not uniform. UKRI requires CC BY for an in-scope research article's open version, with limited permitted exceptions. Wellcome requires CC BY for original research, with a CC BY-ND exception in defined cases. NIH's public-access policy should not be treated as a blanket CC BY requirement. CC BY permits sharing and adaptation with attribution; CC BY-NC restricts commercial reuse; CC BY-ND restricts derivatives. Confirm the licence offered by the journal and required by your funder before submission.